HOME >> BIOLOGY >> NEWS
Chernobyl study: Risk of thyroid cancer rises with radiation dose

SEATTLE The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.

The incidence of thyroid cancer was 45 times greater among those who received the highest radiation dose as compared to those in the lowest-dose group, according to a team of American and Russian researchers led by Scott Davis, Ph.D., and colleagues at Fred Hutchinson Cancer Research Center. They report their findings in the September issue of Radiation Research.

"This is the first study of its kind to establish a dose-response relationship between radiation dose from Chernobyl and thyroid cancer," said Davis, referring to the observation that as radiation doses increase, so does the risk of thyroid cancer. "We found a significant increased risk of thyroid cancer among people exposed as children to radiation from Chernobyl, and that the risk increased as a function of radiation dose."

Having such information in hand, Davis said, may help officials better predict what long-term health effects to expect in the event of a similar nuclear accident or terrorist attack.

"Another potential benefit of the findings is that it allows officials to more accurately understand and document the magnitude of the thyroid-cancer burden that has resulted from Chernobyl. This information will be important in designing and maintaining programs targeted toward the victims of the disaster."

While about 30 people were killed immediately from the blast, which remains the worst accident of its kind in history, an estimated 5 million people were exposed to the resulting radiation.

"Prior to Chernobyl, thyroid cancer in children was practically nonexistent. Today we see dozens and dozens of cases a year in the regions contaminated by the disaster, and the incidence continues to rise," Davis said. "This provides some evidence that there's
'"/>

Contact: Kristen Lidke Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
1-Sep-2004


Page: 1 2 3 4 5 6

Related biology news :

1. Amorous worms reveal effects of Chernobyl
2. Echinacea Symposium Presents New Research On Chernobyl Victims
3. United States And Ukrainian Governments Establish Permanent Chernobyl Laboratory
4. UW study: Migrating birds offer insight into sleep
5. UF study: Barren Siberia, of all places, may be original home to animal life
6. Comprehensive study: We know little about environmental effects on kids
7. UW study: Babys face lights up emotional center of new moms brain
8. UF study: World shark attacks sink again, may signal long-term trend
9. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
10. New study: percentage of babies born with intestinal birth defect growing in U.S., N.C.
11. MIT study: Hydrogen car no environmental panacea

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... ... (NGS) in microbial identification, played a key role in the award-winning study “Next ... by the Rothman Institute. The molecular diagnostic laboratory processed samples using Next Generation ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... form the leading provider of specialized histology, pathology, biomarker development, and archiving ... recently created by the mergers of Histo-Scientific Research Laboratories (HSRL), Vet Path ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... Stanski, MD, a senior pharmaceutical industry executive with expertise in clinical pharmacology and ... drug and disease strategic data analytics, has joined the firm as an Expert ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... ... its Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit ... San Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical ...
(Date:10/22/2019)... , ... October 22, 2019 , ... nQ Medical, Inc. ... School’s 2019 Most Fundable Companies List which was announced at a showcase event yesterday ... million in annual revenue, strong business plans, and impressive near-term growth projections to be ...
(Date:10/22/2019)... (PRWEB) , ... October 22, 2019 , ... ... biotherapeutics, has announced that its lead program, DBI-001, met its primary safety endpoints, ... open labeled phase 2a clinical trial for the treatment of interdigital tinea pedis ...
(Date:10/15/2019)... ... ... an award-winning tech PR agency at the epicenter of the future of PR, today announced ... in the Ragan’s Health Care PR & Marketing Awards. This award marks the second consecutive ... that its healthIT practice group grew by 18 percent in Q3 this year, driven by ...
Breaking Biology Technology:
Cached News: